Date Title Description PDF
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
07 Nov 2024 On P&L A correction to the English version of a document is reported. Download
03 Oct 2024 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the third quarter of 2024 Download
12 Sep 2024 Other relevant information The Company announces the registration in the Commercial Registry of the public deed of reduction of its share capital and the new share capital figure. Download
01 Aug 2024 Other relevant information The Company has agreed to execute the share capital reduction approved by the 2024 Ordinary General Meeting to amortize treasury shares, among which those acquired in the framework of the own shares repurchase program. Download
31 Jul 2024 Liquidity and counterparty agreements Modification of securities and cash balances associated with the Liquidity Contract signed between the Company and Bestinver, S.V., S.A. Download

Pages

Date Title Description PDF
10 May 2018 Otros sobre negocio y situación financiera Update pivotal PRISMA-3 study of DORIA® (Risperidone ISM®) Download
25 Apr 2018 Información sobre resultados ROVI releases the press release related to the 2018 first quarter financial results Download
25 Apr 2018 Convocatorias y acuerdos de Juntas y Asambleas generales ROVI informs about the call for the 2018 Ordinary General Shareholders Meeting Download
25 Apr 2018 Información sobre resultados ROVI releases the 2018 first quarter results presentation Download
04 Apr 2018 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the first quarter of 2018 Download

Pages